Determine if Apparent Diffusion Coefficient (ADC) Values Can Differentiate Tumors From Normal Tissue
Retrospective - Prospective - Study to Determine if Apparent Diffusion Coefficient (ADC) Values Can Differentiate Tumors From Normal Tissues at 3T MRI
1 other identifier
interventional
200
1 country
1
Brief Summary
The purpose of this study is to determine normal measurements (ADC values) from the head and neck of healthy volunteers using 3T MRI.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for early_phase_1
Started Jun 2006
Longer than P75 for early_phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2006
CompletedFirst Submitted
Initial submission to the registry
July 24, 2008
CompletedFirst Posted
Study publicly available on registry
July 28, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2016
CompletedNovember 2, 2016
November 1, 2016
10 years
July 24, 2008
November 1, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
To determine if ADC values determined at 3T are different between normal tissues and tumors arising from the extracranial head and neck.
1 year
Study Arms (1)
A
EXPERIMENTALTo determine if apparent diffusion coefficient values can differentiate tumors from normal tissues using a 3T MRI scan.
Interventions
Establishing/evaluating apparent diffusion coefficient (ADC) values using a 3T MRI scan to differentiate tumors from normal tissue.
Eligibility Criteria
You may qualify if:
- Healthy subjects 18 years of age or older.
You may not qualify if:
- Under 18 years of age
- Women of child bearing potential
- Pregnant or lactating women
- All potential volunteers will be pre-screened by MRI personnel to determine if there is any medical reason that you should not be included in this study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Michiganlead
- National Institutes of Health (NIH)collaborator
Study Sites (1)
University of Michigan Health System
Ann Arbor, Michigan, 48109, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ashok Srinivasan, M.D.
University of Michigan
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 24, 2008
First Posted
July 28, 2008
Study Start
June 1, 2006
Primary Completion
June 1, 2016
Study Completion
July 1, 2016
Last Updated
November 2, 2016
Record last verified: 2016-11
Data Sharing
- IPD Sharing
- Will not share